Salarius Pharmaceuticals Inc (SLRX) Price Targets From Analysts
Use the tables below to see what analysts covering Salarius Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
SLRX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- SLRX has a greater upside potential (average analyst target price relative to current price) than 94.81% of all US stocks.
- The average analyst price target of SLRX is higher than 7.25% of all US stocks.
- SLRX has a greater number of analysts covering the stock than 23.57% of Pharmaceutical Products stocks.
- SLRX has a lower variance in analysts' estimates than 68.37% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, MDNA, LPCN and AYTU are the three stocks most similar to Salarius Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
What is the outlook for SLRX? Use POWR Ratings for clearer insight into price direction.